Neuralstem Story Overview

CUR -- USA Stock  

USD 1.21  0.004  0.33%

Macroaxis does not monitor all media channels or aggregates social signals for Neuralstem. But even though we do not provide professional-grade financial sentiment analysis on Neuralstem, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Neuralstem. Check also Neuralstem Hype Analysis, Neuralstem Correlation and Neuralstem Performance.
Taking a Fresh Look at Neuralstem, Inc.
In recent action, Neuralstem, Inc. has made a move of 79.46 percent over the past month, which has come on weak relative transaction volume. Reading the Tea Leaves for Neuralstem, Inc. - Economic News Broker Roundup on Neuralstem Inc - ExpertGazette

Read More...   

Story Momentum

This article from www.stocknewsjournal.com published on 07 of December contributed to the next trading period closing price depreciation.The overall trading delta to the next next day price was 10.71% . The trading delta at closing time when the story was published to current price is 46.88% .

Similar stores for Neuralstem

Nuance Investments Lifted By 6.66 Million Its Aflac Holding Neuralstem Sellers Increased By 2.45 ...news
The Cardinal Weekly Full coverage
over a week ago at http://simplywall.st 
Neuralstem Inc Risks You Need To Consider Before Buying
news
Simply Wall StFull coverage
over three weeks ago at http://www.thewellesleysnews.com 
Analyst Opinion Summary TDH Holdings, Inc. , Neuralstem, Inc.
news
Analyst JournalFull coverage
over a month ago at http://marketexclusive.com 
OPIANT PHARMACEUTICALS, INC. Files An 8-K Departure of Directors or Certain Officers Election ...
news
Market ExclusiveOpiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors Markets InsiderForm 8-K OPIANT PHARMACEUTICALS, For Jun 12 StreetInsider.comFull coverage
over a month ago at www.macroaxis.com 
Acquisition by Conron John of 50000 shares of Neuralstem subject to Rule 16b-3
Macroaxis News
Filed transaction by Neuralstem Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at http://www.thestreetpoint.com 
Dynamic volume-return relation of individual stocks Iconix Brand Group, Inc. , Gold Standard Ventures ...
Thestreet News
The Stock Street Full coverage
over two months ago at http://www.streetinsider.com 
Form 10-Q Neuralstem, Inc. For Mar 31
Street Insider News
StreetInsider.comFull coverage
over two months ago at http://www.thestreetpoint.com 
Attention-Grabbing Stocks Neuralstem, Inc. , Retractable Technologies, Inc.
Thestreet News
The Stock Street Full coverage
over two months ago at http://mostvolatilestocks.com 
Stock Performance Summary Neuralstem, Inc.
news
MostVolatileStocks Full coverage
over two months ago at http://www.concordiareview.com 
Are Cagey Traders Interested in Neuralstem, Inc.
news
Concordia ReviewFull coverage
over three months ago at http://mostvolatilestocks.com 
Eye Catching Stock for Investors Neuralstem, Inc.
news
MostVolatileStocks Full coverage
over three months ago at http://globenewswire.com 
Neuralstem to Participate at Cell and Gene Therapy World
news
Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need. Somewhat Positive Press Coverage Somewhat Unlikely to Impact Neuralstem CUR ... - The Lincolnian Online
over six months ago at http://www.thestreetpoint.com 
Wining Stock- Neuralstem, Inc.
Thestreet News
Neuralstem, Inc. beta is 1.60 whilst the stock has an average true range of 0.29. Other technical indicators are worth considering in assessing the prospects for EQT.

EBITDA

EBITDA Comparative Analysis
  EBITDA 
      Neuralstem Comparables 
Neuralstem is currently under evaluation in ebitda category among related companies. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Peers

Neuralstem Related Equities
DVAX  5.32 %   
0%
100.0%
DRNA  4.95 %   
0%
92.0%
DOVA  3.61 %   
0%
67.0%
ECYT  2.97 %   
0%
55.0%
CO  1.01 %   
0%
18.0%
DNLI  0.36 %   
6.0%
0%
NK  0.64 %   
12.0%
0%
EARS  0.79 %   
14.0%
0%
EDGE  0.97 %   
18.0%
0%
DMPI  4.55 %   
85.0%
0%
Check also Neuralstem Hype Analysis, Neuralstem Correlation and Neuralstem Performance. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.